Protein metabolism in patients with chronic renal failure: Role of uremia and dialysis

Kidney International

Volumn 58, Issue 1, 2000, Pages 1-10

  Lim, Victoria S ^a,b,c,d   Kopple, Joel D ^a,b,c  

^a UNIVERSITY OF IOWA   (United States)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

Author keywords

Dialysis; Protein metabolism; Uremia

Indexed keywords

CYTOKINE; INSULIN; PROTEIN; SOMATOMEDIN C;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANOREXIA; CHRONIC KIDNEY FAILURE; CONTROLLED STUDY; DIALYSIS; HORMONE RESISTANCE; METABOLIC ACIDOSIS; NITROGEN BALANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN CALORIE MALNUTRITION; PROTEIN DEGRADATION; PROTEIN INTAKE; RAT; REVIEW; UREMIA;

EID: 0033919815     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2000.00135.x     Document Type: Article

References (89)

1. 1. KOPPLE JD: McCollum Award Lecture, 1996: Protein-energy malnutrition in maintenance dialysis patients. Am J Clin Nutr 65:1544-1557, 1997
2. 2. BERGSTRÖM J: Why are dialysis patients malnourished? Am J Kidney Dis 26:229-241, 1995
3. 3. IKIZLER TA, HAKIM RM: Nutrition in end-stage renal disease. Kidney Int 50:343-357, 1996
4. 4. DELAPORTE C, GROS F, ANAGNOSTOPOULOS T: Inhibitory effects of plasma dialysate on protein synthesis in vitro: Influence of dialysis and transplantation. Am J Clin Nutr 33:1407-1410, 1980
5. 5. DINARELLO CA, ROUBENOFF RA: Mechanisms of loss of lean body mass in patients on chronic dialysis. Blood Purif 14:388-394, 1996
6. 6. GUTIERREZ A: Protein catabolism in maintenance haemodialysis: The influence of the dialysis membrane. Nephrol Dial Transplant 11(Suppl 2):108-111, 1996
7. 7. GUARNIERI G, TOIGO G, FIOTTI N, CIOCCHI B, SITULIN R, GIANSANTE C, VASILE A, CARRARO M, FACCINI L, BIOLO G: Mechanisms of malnutrition in uremia. Kidney Int 52(Suppl 62):S41-S44, 1997
8. 8. REAICH D, PRICE SR, ENGLAND BK, MITCH WE: Mechanisms causing muscle loss in chronic renal failure. Am J Kidney Dis 26:242-247, 1995
9. 9. LI JB, WASSNER SJ: Muscle degradation in uremia: 3-methylhistidine release in fed and fasted rats. Kidney Int 20:321-325, 1981
10. 10. HOLLIDAY MA, CHANTLER C, MACDONNELL R, KEITGES J: Effect of uremia on nutritionally-induced variations in protein metabolism. Kidney Int 11:236-245, 1977
11. 11. BALIGA R, GEORGE VT, RAY PE, HOLLIDAY MA: Effects of reduced renal function and dietary protein on muscle protein synthesis. Kidney Int 39:831-835, 1991
12. 12. GARBER AJ: Skeletal muscle protein and amino acid metabolism in experimental chronic uremia in the rat. J Clin Invest 62:623-632, 1978
13. 13. GARBER AJ: Effects of parathyroid hormone on skeletal muscle protein and amino acid metabolism in the rat. J Clin Invest 71:1806-1821, 1983
14. 14. HARTER HR, KARL IE, KLAHR S, KIPNIS DM: Effects of reduced renal mass and dietary protein intake on amino acid release and glucose uptake by rat muscle in vitro. J Clin Invest 64:513-523, 1979
15. 15. HARTER HR, BIRGE SJ, MARTIN KJ, KLAHR S, KARL IE: Effects of vitamin D metabolites on protein catabolism of muscle from uremic rats. Kidney Int 23:465-472, 1983
16. 16. DAVIS TA, KARL IE, TEGTMEYER ED, OSBORNE DF, KLAHR S, HARTER HR: Muscle protein turnover: Effects of exercise training and renal insufficiency. Am J Physiol 248:E337-E345, 1985
17. 17. MAY RC, KELLY RA, MITCH WE: Mechanisms for defects in muscle protein metabolism in rats with chronic uremia. J Clin Invest 79:1099-1103, 1987
18. 18. HARA Y, MAY RC, KELLY RA, MITCH WE: Acidosis, not azotemia, stimulates branched-chain, amino acid catabolism in uremic rats. Kidney Int 32:808-814, 1987
19. 19. ENGLAND BK, GREIBER S, MITCH WE, BOWERS BA, HERRING WJ, MCKEAN M, EBB RG, PRICE R, DANNER DJ: Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. Am J Physiol 268:C1395-C1400, 1995
20. 20. BAILEY JL, WANG X, ENGLAND BK, PRICE SR, DING X, MITCH WE: The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest 97:1447-1453, 1996
21. 21. WING SS, GOLDBERG AL: Glucocorticoids activate the ATP-ubiquitin-dependent proteolytic system in skeletal muscle during fasting. Am J Physiol 264:E668-E676, 1993
22. 22. KOPPLE JD, COBURN JW: Metabolic studies of low protein diets in uremia. I. Nitrogen and potassium. Medicine (Baltimore) 52:583-595, 1973
23. 23. KOPPLE JD, SWENDSEID ME: Evidence that histidine is an essential amino acid in normal and chronically uremic man. J Clin Invest 55:881-891, 1975
24. 24. KOPPLE JD: Treatment with low protein and amino acid diets in chronic renal failure, in Proceedings of the VII International Congress of Nephrology, Basel, S Karger, 1978, pp 497-507
25. 25. KOPPLE JD, SWENDSEID ME: Nitrogen balance and plasma amino acid levels in uremic patients fed an essential amino acid diet. Am J Clin Nutr 27:806-812, 1974
26. 26. FORD J, PHILLIPS ME, TOYE FE, LUCK VA, DE WARDENER HE: Nitrogen balance in patients with chronic renal failure on diets containing varying quantities of protein. Br Med J 1:735-740, 1969
27. 27. MARONI BJ, STEINMAN TI, MITCH WE: A method of estimating nitrogen intake of patients with chronic renal failure. Kidney Int 27:58-65, 1985
28. 28. BERGSTRÖM J, FÜRST P, NORÉE LO: Treatment of chronic uremic patients with protein-poor diet and oral supply of essential amino acids. I. Nitrogen balance studies. Clin Nephrol 3:187-194, 1975
29. 29. MITCH WE, ABRAS E, WALSER M: Long-term effects of a new ketoacid-amino acid supplement in patients with chronic renal failure. Kidney Int 22:48-53, 1982
30. 30. MITCH WE, WALSER M, STEINMAN TI, HILL S, ZEGER S, TUNGSANGA K: The effect of ketoacid-amino acid supplement to a restricted diet on the progression of chronic renal failure. N Engl J Med 11:623-629, 1984
31. 31. IHLE BU, BECKER GJ, WHITWORTH JA, CHARLWOOD RA, KINCAID-SMITH PS: The effect of protein restriction on the progression of renal insufficiency. N Engl J Med 321:1773-1777, 1989
32. 32. KOPPLE JD, LEVEY AS, GREENE T, CHUMLEA WC, GASSMAN JJ, HOLLINGER DL, MARONI BJ, MERRILL D, SCHERCH LK, SCHULMAN G, WANG SR, ZIMMER GS: Effect of dietary protein restriction on nutritional status in the Modification of Diet in Renal Disease Study. Kidney Int 52:778-791, 1997
33. 33. KOPPLE JD, SHINABERGER JH, COBURN JW, SORENSEN MK, RUBINI ME: Optimal dietary protein treatment during chronic hemodialysis. Trans Am Soc Artif Intern Organs 15:302-308, 1969
34. 34. BORAH MF, SCHOENFELD PY, GOTCH FA, SARGENT JA, WOLFSON M, HUMPHREYS MH: Nitrogen balance during intermittent dialysis therapy of uremia. Kidney Int 14:491-500, 1978
35. 35. SLOMOWITZ LA, MONTEON FJ, GROSVENOR M, LAIDLAW SA, KOPPLE JD: Effect of energy intake on nutritional status in maintenance hemodialysis patients. Kidney Int 35:704-711, 1989
36. 36. LIM VS, FLANIGAN MJ, ZAVALA DC, FREEMAN RM: Protective adaptation of low serum triiodothyronine in patients with chronic renal failure. Kidney Int 28:541-549, 1985
37. 37. BLUMENKRANTZ MJ, KOPPLE JD, MORAN JK, GRODSTEIN GP, COBURN JW: Nitrogen and urea metabolism during continuous ambulatory peritoneal dialysis. Kidney Int 20:78-82, 1981
38. 38. GIORDANO C, DE SANTO NG, PLUVIO M, DI LEO VA, CAPODICASA G, CIRILLO D, ESPOSITO R, DAMIANO M: Protein requirement of patients on CAPD: A study on nitrogen balance. Int J Artif Organs 3:11-14, 1980
39. 39. BERGSTRÖM J, FÜRST P, ALVESTRAND A, LINDHOLM B: Protein and energy intake, nitrogen balance and nitrogen losses in patients treated with continuous ambulatory peritoneal dialysis. Kidney Int 44:1048-1057, 1993
40. 40. DEFERRARI G, GARIBOTTO G, ROBAUDO C, CANEPA A, BAGNASCO S, TIZIANELLO A: Leg metabolism of amino acids and ammonia in patients with chronic renal failure. Clin Sci 69:143-151, 1985
41. 41. ALVESTRAND A, DEFRONZO RA, SMITH D, WAHREN J: Influence of hyperinsulinemia on intracellular amino acid levels and amino acid exchange across splanchnic and leg tissues in uremia. Clin Sci 74:155-163, 1988
42. 42. GARIBOTTO G, RUSSO R, SOFIA A, SALA MR, ROBAUDO C, MOSCATELLI P, DEFERRARI G, TIZIANELLO A: Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int 45:1432-1439, 1994
43. 13C] leucine. Am J Physiol 238:E473-E479, 1980
44. 44. GOODSHIP THJ, MITCH WE, HOERR RA, WAGNER DA, STEINMAN TI, YOUNG VR: Adaption to low-protein diets in renal failure: Leucine turnover and nitrogen balance. J Am Soc Nephrol 1:66-75, 1990
45. 45. LIM VS, TSALIKIAN E, FLANIGAN MJ: Augmentation of protein degradation by 1-triiodothyronine in uremia. Metabolism 38:1210-1215, 1989
46. 13C-leucine. Am J Clin Nutr 46:778-783, 1987
47. 47. GOODSHIP THJ, LLOYD S, CLAGUE MB, BARTLETT K, WARD MK, WILKINSON R: Whole body leucine turnover and nutritional status in continuous ambulatory peritoneal dialysis. Clin Sci 73:463-469, 1987
48. 48. CONLEY SB, ROSE GM, ROBSON AM, BIER DM: Effects of dietary intake and hemodialysis on protein turnover in uremic children. Kidney Int 17:837-846, 1980
49. 49. SHALDON S, ELIE M, KOCH KM, DINARELLO CA: Interleukin-1 stimulation in the ESRD patient: Potential long-term consequences. Transplant Proc 19:4353-4357, 1987
50. 50. LAUDE-SHARP M, CAROFF M, SIMARD L, PUSINERI C, KAZATCHKINE MD, HAEFFNER-CAVAILLON N: Induction of IL-1 during hemodialysis: Transmembrane passage of intact endotoxins (LPS). Kidney Int 38:1089-1094, 1990
51. 51. FARRELL PC, HONE PW: Dialysis-induced catabolism. Am J Clin Nutr 33:1417-1422, 1980
52. 52. WARD RA, SHIRLOW MJ, HAYES JM, CHAPMAN GV, FARRELL PC: Protein catabolism during hemodialysis. Am J Clin Nutr 32:2443-2449, 1979
53. 53. LIM VS, FLANIGAN MJ: The effect of interdialytic interval on protein metabolism: Evidence suggesting dialysis-induced catabolism. Am J Kidney Dis 14:96-100, 1989
54. 54. GUTIERREZ A, ALVESTRAND A, WAHREN J, BERGSTRÖM J: Effect of in vivo contact between blood and dialysis membranes on protein catabolism in humans. Kidney Int 38:487-494, 1990
55. 55. LIM VS, BIER DM, FLANIGAN MJ, SUM-PING ST: The effect of hemodialysis on protein metabolism. J Clin Invest 91:2429-2436, 1993
56. 56. LINDSAY RM, SPANNER E: A hypothesis: The protein catabolic rate is dependent upon the type and amount of treatment in dialyzed uremic patients. Am J Kidney Dis 13:382-389, 1989
57. 57. IKIZLER TA, FLAKOLL PJ, PARKER RA, HAKIM RA: Amino acid and albumin losses during hemodialysis. Kidney Int 46:830-837, 1994
58. 58. KAPLAN AA, HALLEY SE, LAPKIN RA, GRAEBER CW: Dialysate protein losses with bleach processed polysulphone dialyzers. Kidney Int 47:573-578, 1995
59. 59. LIM VS, YARASHESKI KE, FLANIGAN MJ: The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: A longitudinal leucine kinetic study. Nephrol Dial Transplant 13:1723-1730, 1998
60. 60. PAPADOYANNAKIS NJ, STEFANIDIS CJ, MCGEOWN M: The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nutr 40:623-627, 1984
61. 61. WILLIAMS B, HATTERSLEY J, LAYWARD E, WALLS J: Metabolic acidosis and skeletal muscle adaptation in low protein diets in chronic uremia. Kidney Int 40:779-786, 1991
62. 62. REAICH D, CHANNON SM, SCRIMGEOUR CM, DALEY SE, WILKINSON R, GOODSHIP THJ: Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol 265:E230-E235, 1993
63. 63. GRAHAM KA, REAICH D, CHANNON SM, DOWNIE S, GOODSHIP THJ: Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol 8:632-637, 1997
64. 64. MITCH WE, CLARK AS: Muscle protein turnover in uremia. Kidney Int 24(Suppl 16):S2-S8, 1983
65. 65. DING H, GAO XL, HIRSCHBERG R, VADGAMA JV, KOPPLE JD: Impaired actions of insulin-like growth factor 1 on protein synthesis and degradation in skeletal muscle of rats with chronic renal failure: Evidence for a postreceptor defect. J Clin Invest 97:1064-1075, 1996
66. 66. REAICH D, GRAHAM KA, CHANNON SM, HETHERINGTON C, SCRIMGEOUR CM, WILKINSON R, GOODSHIP THJ: Insulin-mediated changes in PD and glucose uptake after correction of acidosis in humans with CRF. Am J Physiol 268:E121-E126, 1995
67. 67. CASTELLINO P, SOLINI A, LUZI L, BARR JG, SMITH DJ, PETRIDES A, GIORDANO M, CARROLL C, DEFRONZO RA: Glucose and amino acid metabolism in chronic renal failure: Effect of insulin and amino acids. Am J Physiol 262:F168-F176, 1992
68. 68. FOUQUE D, PENG SC, KOPPLE JD: Impaired metabolic response to recombinant insulin-like growth factor-1 in dialysis patients. Kidney Int 47:876-883, 1995
69. 69. FOUQUE D, PENG SC, SHAMIR E, KOPPLE JD: Recombinant human IGF-1 induces an anabolic response in malnourished CAPD patients. Kidney Int 56:2269-2275, 1999
70. 70. HENDERSON LW, KOCH KM, DINARELLO CA, SHALDON S: Hemodialysis hypotension: The interleukin hypothesis. Blood Purif 1:3-8, 1983
71. 71. PEREIRA BJG, SHAPIRO L, KING AJ, FALAGAS ME, STROM JA, DINARELLO CA: Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure, CAPD and hemodialysis patients. Kidney Int 45:890-896, 1994
72. 72. LEEUWENBERG JFM, MAT O, ABRAMOWICZ D, GASTALDELLO R, TEILEMANS C, BUURMAN WA: Increased plasma levels of soluble tumor necrosis factor-receptors in uraemic patients: Effects of dialysis, type of membrane, and anticoagulation method. Nephrol Dial Transplant 9:1125-1129, 1994
73. 73. BRAUNER A, HYLANDER B, WRETLIND B: Tumor necrosis factor-α, interleukin-1β, and interleukin-1 receptor antagonist in dialysate and serum from patients on continuous ambulatory peritoneal dialysis. Am J Kidney Dis 27:402-408, 1996
74. 74. HERBELIN A, UREÑA P, NGUYEN AT, ZINGRAFF J, DESCAMPSLATSCHA B: Elevated circulating levels of interleukin-6 in patients with chronic renal failure. Kidney Int 39:954-960, 1991
75. 75. NAKANISHI I, MOUTABARRIK A, OKADA N, KITAMURA E, HAYASHI A, SYOUJI T, NAMIKI M, ISHIBASHI M, ZAID D, TSUBAKIHARA Y: Interleukin-8 in chronic renal failure and dialysis patients. Nephrol Dial Transplant 9:1435-1442, 1994
76. 76. OWEN WF, LOWRIE EG: C-reactive protein as an outcome predictor for maintenance hemodialysis patients. Kidney Int 54:627-636, 1998
77. 77. KAYSEN GA: Biological basis of hypoalbuminemia in ESRD. J Am Soc Nephrol 9:2368-2376, 1998
78. 78. KAYSEN GA, RATHORE V, SHEARER GC, DEPNER TA: Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int 48:510-516, 1995
79. 2 release by leukocytic pyrogen (interleukin-1): A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 308:553-558, 1983
80. 80. WEINBLATT ME, KREMER JM, BANKHURST AD, BULPITT KJ, FLEISCHMANN RM, FOX RI, JACKSON CG, LANGE M, BURGE DJ: A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 340:253-259, 1999
81. 81. Recommended Dietary Allowances (10th ed). Washington, DC., Subcommittee on the Tenth Edition of the RDAs Food and Nutrition Board, Commission on Life Sciences, National Research Council, National Academy Press, 1989
82. 82. WOLFSON M, JONES MR, KOPPLE JD: Amino acid losses during hemodialysis with infusion of amino acids and glucose. Kidney Int 21:500-506, 1982
83. 83. BLUMENKRANTZ MJ, GAHL GM, KOPPLE JD, KAMDAR AV, JONES MR, KESSEL M, COBURN JW: Protein losses during peritoneal dialysis. Kidney Int 19:593-602, 1981
84. 84. KOPPLE JD, SWENDSEID MD, SHINABURGER JH, UMEZAWA CY: The free and bound amino acids removed by hemodialysis. Trans Am Soc Artif Intern Organs 19:309-313, 1973
85. 85. LIM VS, ZAVALA DC, FLANIGAN MJ, FREEMAN RM: Blunted peripheral tissue responsiveness to thyroid hormone in uremic patients. Kidney Int 31:808-814, 1987
86. 86. OLEVITCH LR, BOWERS BM, DEOREO PB: Measurement of resting energy expenditure via indirect calorimetry among adult hemodialysis patients. J Ren Nutr 4:192-197, 1994
87. 87. IKIZLER TA, WINGARD RL, SUN M, HARVELL J, PARKER RA, HAKIM RM: Increased energy expenditure in hemodialysis patients. J Am Soc Nephrol 7:2646-2653, 1996
88. 88. KOPPLE JD: Dietary protein and energy requirements in ESRD patients. Am J Kidney Dis 32(Suppl 4):S97-S104, 1996
89. 89. NATIONAL KIDNEY FOUNDATION: Nutrition DOQI clinical practice guidelines on nutrition in chronic renal failure: Recommendations. Am J Kidney Dis (in press)